- Home
- MRNA vs LNG Comparison
MRNA vs LNG Comparison
Compare MRNA & LNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | LNG |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 57.5B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MRNA | LNG |
|---|---|---|
| Price | $182.10 | $272.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 15 |
| Target Price | $34.27 | ★ $294.87 |
| AVG Volume (30 Days) | ★ 16.6M | 2.0M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | 21.77 | ★ 69.93 |
| EPS | N/A | ★ N/A |
| Revenue | $19,263,000,000.00 | ★ $19,976,000,000.00 |
| Revenue This Year | $9.36 | $16.48 |
| Revenue Next Year | $15.43 | $5.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.29 | ★ 27.21 |
| 52 Week Low | $22.28 | $186.20 |
| 52 Week High | $176.86 | $300.94 |
Technical Indicators
Market Signals| Indicator | MRNA | LNG |
|---|---|---|
| Relative Strength Index (RSI) | 68.50 | 45.64 |
| Support Level | $46.85 | $250.03 |
| Resistance Level | $176.66 | $276.17 |
| Average True Range (ATR) | 9.39 | 6.39 |
| MACD | 0.06 | -2.13 |
| Stochastic Oscillator | 87.11 | 18.17 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About LNG Cheniere Energy Inc.
Cheniere Energy is a liquefied natural gas producer with two facilities in Corpus Christi, Texas, and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.